Expert Pitch

Government faces hard task of scaling small business relief

Cornell University
31-Mar-2020 1:05 PM EDT, by Cornell University

Government faces hard task of scaling small business relief The government’s $2 trillion stimulus package includes relief for small businesses that are hurting due to the coronavirus pandemic. Among the stimulus provisions are more than $350 billion in loans and payroll tax relief destined to help small and medium firms, those who are self-employed as well as freelancers and gig workers.

Tom Schryver is visiting lecturer at the SC Johnson College of Business at Cornell University where he teaches entrepreneurship and business strategy. He says that in helping small businesses, the government is walking a line between getting things done fast and offering the perfect solutions.

Bio: Schryver says: “The economic injury disaster loan program by the Small Business Administration (SBA) provides loan amounts of up to $2 million; and provisions that provide exceptions to equity-holders needing to personally guarantee the loan.

The SBA is staffed with great, hard-working people, but typical SBA loan programs are administered by the banks. It will be a heavy lift for the SBA to be on the front lines with all these potential borrowers, and it remains to be seen if they can scale up fast enough. “Also, borrowers must be able to show ‘economic injury’ from the pandemic and the funds need to be used for payroll, working capital and debt repayment that would otherwise be stuck without the loan. What we’re seeing are two types of companies – in one case firms are indeed struggling to hold on, and these kinds of loans will help them keep the lights on and hopefully avoid layoffs, at least avoid them for longer. The other type are companies trying to figure out how to deal with enormous upticks in volume, if they’re in home delivery or e-commerce businesses, for example. These businesses need capital for growth but are not of the type that are likely to be able to show ‘economic injury’ and therefore will have difficulty accessing these loans.

“At the end of the day, this crisis is moving very fast, the impacts are large, and we see governments doing the best they can to deploy what are, at best, blunt instruments. Over time, I’m confident that programs will adapt and become more nuanced to best fit those in need, but one can definitely see policy being made with a philosophy of ‘perfect is the enemy of done’ – and, given the depth of the need of so many small businesses, that seems like an appropriate trade-off.”

- 30 -


Filters close

Showing results

110 of 5639
access_time Embargo lifts in 2 days
Embargo will expire: 20-May-2021 10:00 AM EDT Released to reporters: 14-May-2021 2:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-May-2021 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 14-May-2021 11:25 AM EDT
Access to overdose-reversing drugs declined during pandemic, researchers find
Beth Israel Lahey Health

In a new study, clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) analyzed naloxone prescription trends during the COVID-19 pandemic in the United States and compared them to trends in opioid prescriptions and to overall prescriptions.

Released: 14-May-2021 11:00 AM EDT
No Excuses: Stop Procrastinating on These Key Health Checks
Michigan Medicine - University of Michigan

A quick guide to the most-valuable preventive care that adults need to get scheduled, to catch up on what they may have missed during the height of the pandemic, and to address issues that the pandemic might have worsened.

Released: 13-May-2021 7:05 PM EDT
FLCCC Statement on the Irregular Actions of Public Health Agencies & the Disinformation Campaign Against Ivermectin
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

FLCCC Alliance calls for whistleblower to step forward from within WHO, the FDA, the NIH, Merck, or Unitaid to counter this misrepresentation

Newswise: shutterstock_1724336896.jpg
Released: 13-May-2021 12:55 PM EDT
Kreuter receives $1.9 million in grants to increase vaccinations in St. Louis
Washington University in St. Louis

Matthew Kreuter, the Kahn Family Professor of Public Health at the Brown School, has received $1.9 million in grants to help increase COVID-19 vaccinations among Blacks in St. Louis City and County.

Released: 13-May-2021 11:35 AM EDT
COVID-19 mRNA Vaccines are Immunogenic in Pregnant and Lactating Women, Including Against Viral Variants
Beth Israel Deaconess Medical Center

In a new study from Beth Israel Deaconess Medical Center researchers evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women who received either the Pfizer or Moderna COVID-19 vaccines. They found that both vaccines triggered immune responses in pregnant and lactating women.

Released: 13-May-2021 10:30 AM EDT
Pandemic stigma: Foreigners, doctors wrongly targeted for COVID-19 spread in India
Monash University

The Indian public blamed foreigners, minority groups and doctors for the rapid spread of COVID-19 across the country during the first wave, due to misinformation, rumour and long-held discriminatory beliefs, according to an international study led by Monash University.

Released: 13-May-2021 9:15 AM EDT
28 Community Programs Receive Grants Through Penn Medicine CAREs Program
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine CAREs awarded grants to 28 projects, many of which aim to fill vast needs in the community created by the COVID-19 pandemic, while others seek to improve diversity, equity, and inclusion.

Showing results

110 of 5639